{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5","upperLimit":"6","value":"5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"}],"units":"Participants"}],"description":"Number (median and 95% confidence interval) of days to reach 6 million CD34 cells/kg was estimated using the Kaplan Meier method. Participants were lower than 6 million CD34 cells/kg at time of last follow-up will be censored at that date.","dispersionType":"95% Confidence Interval","groups":[{"description":"Plerixafor 160mg/kg/dose by IV on days 5-8\n\nFilgrastim (G-CSF) 10 mg/kg/dose subcutaneously on days 1-8.","id":"OG000","title":"Plerixafor"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Duration of apheresis (up to 7 days)","title":"Time to Reach 6 Million CD34 Cells","type":"SECONDARY","unitOfMeasure":"days"}